Evidence map›Paper›PMID 24415540›Full record

ArticleBlood2014

Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.

Kaifeng Lisa Lin, LeShara M Fulton, Matthew Berginski, Michelle L West, Nicholas A Taylor, Timothy P Moran, James M Coghill, Bruce R Blazar, James E Bear, Jonathan S Serody

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.The Journal of experimental medicine · 2017
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Intravital multiphoton imaging of cutaneous immune responses.The Journal of investigative dermatology · 2014
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Kaifeng Lisa LinLineberger Comprehensive Cancer Center.
LeShara M Fulton
Matthew Berginski
Michelle L West
Nicholas A Taylor
Timothy P Moran
James M Coghill
Bruce R Blazar
James E Bear
Jonathan S Serody
Segeberger Kliniken · DEUNC Lineberger Comprehensive Cancer CenterDuke University · USMasonic Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Mark J Osborn · 1995 to 2026
$48.2M
Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 2003 to 2023
$42.5M
Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host DiseaseP01CA142106 · NCI · DANA-FARBER CANCER INST · PI CUTLER, COREY S · 2009 to 2019
$17.5M
Enhancing Treg Therapeutic Efficacy in GVHDR01HL118979 · NHLBI · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, HIPPEN, KELI L · 2014 to 2025
$6.7M
IN VIVO PREVENTION OF MURINE GVHDR01AI034495 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1993 to 2016
$6.2M
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGYT32AI007062 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David B. Peden, John W. Sleasman · 1985 to 2026
$6.1M
T-CELL TARGETING FOR GVHDR01HL056067 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1995 to 2022
$5.4M
GVL TO REDUCE AML RELAPSE AFTER MURINE ALLOGENEIC BMTR01CA072669 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1997 to 2017
$4.9M
Effect of breast feeding on immunologic priming in young infants.R01AI100147 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI SLEASMAN, JOHN W. · 2012 to 2016
$2.5M
Treg Migration in GVHDR01AI064363 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2005 to 2009
$2.0M
Th1/Th17 Macrophage Interactions in Cutaneous GVHDR01CA166794 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2012 to 2016
$1.5M
Targeting CCR7 for the Prevention/Treatment of GvHDR01HL115761 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2012 to 2015
$1.4M
NCI NIH HHS P01 CA065493NCI NIH HHS P01 CA142106NCI NIH HHS R01 CA072669NCI NIH HHS R01 CA166794NCI NIH HHS R01CA166794NHLBI NIH HHS R01 HL056067NHLBI NIH HHS R01 HL115761NHLBI NIH HHS R01HL115761NHLBI NIH HHS R01 HL118979NHLBI NIH HHS R01HL56067NIAID NIH HHS P01 AI056299NIAID NIH HHS R01 AI034495NIAID NIH HHS R01 AI064363NIAID NIH HHS R01AI064363NIAID NIH HHS R01 AI100147NIAID NIH HHS T32 AI007062PHS HHS P0IAI056299
6 · The paper itself

Abstract

Graft-versus-host disease (GVHD) is a systemic inflammatory response due to the recognition of major histocompatibility complex disparity between donor and recipient after hematopoietic stem cell transplantation (HSCT). T-cell activation is critical to the induction of GVHD, and data from our group and others have shown that regulatory T cells (Tregs) prevent GVHD when given at the time of HSCT. Using multiphoton laser scanning microscopy, we examined the single cell dynamics of donor T cells and dendritic cells (DCs) with or without Tregs postallogeneic transplantation. We found that donor conventional T cells (Tcons) spent very little time screening host DCs. Tcons formed stable contacts with DCs very early after transplantation and only increased velocity in the lymph node at 20 hours after transplant. We also observed that Tregs reduced the interaction time between Tcons and DCs, which was dependent on the generation of interleukin 10 by Tregs. Imaging using inducible Tregs showed similar disruption of Tcon-DC contact. Additionally, we found that donor Tregs induce host DC death and down-regulate surface proteins required for donor T-cell activation. These data indicate that Tregs use multiple mechanisms that affect host DC numbers and function to mitigate acute GVHD.

Indexed as

AnimalsB7-2 AntigenCell CommunicationCell DeathDendritic CellsDisease Models, AnimalGraft vs Host DiseaseHematopoietic Stem Cell TransplantationIntercellular Adhesion Molecule-1Lymphocyte ActivationMiceMice, TransgenicT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsTransplantation, HomologousB7-2 AntigenIntercellular Adhesion Molecule-1

Identifiers

PMID24415540
PMCPMC3945868
OpenAlexW2154871915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.